MD-2 binds to bacterial lipopolysaccharide
- PMID: 11500507
- DOI: 10.1074/jbc.M105228200
MD-2 binds to bacterial lipopolysaccharide
Abstract
The exact roles and abilities of the individual components of the lipopolysaccharide (LPS) receptor complex of proteins remain unclear. MD-2 is a molecule found in association with toll-like receptor 4. We produced recombinant human MD-2 to explore its LPS binding ability and role in the LPS receptor complex. MD-2 binds to highly purified rough LPS derived from Salmonella minnesota and Escherichia coli in five different assays; one assay yielded an apparent KD of 65 nm. MD-2 binding to LPS did not require LPS-binding proteins LBP and CD14; in fact LBP competed with MD-2 for LPS. MD-2 enhanced the biological activity of LPS in toll-like receptor 4-transfected Chinese hamster ovary cells but inhibited LPS activation of U373 astrocytoma cells and of monocytes in human whole blood. These data indicate that MD-2 is a genuine LPS-binding protein and strongly suggest that MD-2 could play a role in regulation of cellular activation by LPS depending on its local availability.
Similar articles
-
MD-2 binds to bacterial lipopolysaccharide.J Endotoxin Res. 2000;6(6):489-91. J Endotoxin Res. 2000. PMID: 11521076
-
Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influencedby endotoxin concentration.Eur J Biochem. 2000 Apr;267(8):2218-26. doi: 10.1046/j.1432-1327.2000.01222.x. Eur J Biochem. 2000. PMID: 10759844
-
Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved.J Biol Chem. 2003 May 2;278(18):15587-94. doi: 10.1074/jbc.M212829200. Epub 2003 Feb 19. J Biol Chem. 2003. PMID: 12594207
-
LPS induction of gene expression in human monocytes.Cell Signal. 2001 Feb;13(2):85-94. doi: 10.1016/s0898-6568(00)00149-2. Cell Signal. 2001. PMID: 11257452 Review.
-
Altuğ Tuncel, MD, FEBU.J Endourol. 2025 Aug 22. doi: 10.1177/08927790251372287. Online ahead of print. J Endourol. 2025. PMID: 40844592 Review. No abstract available.
Cited by
-
Toll-like receptor 4 activation in cancer progression and therapy.Clin Dev Immunol. 2011;2011:609579. doi: 10.1155/2011/609579. Epub 2011 Nov 3. Clin Dev Immunol. 2011. PMID: 22110526 Free PMC article. Review.
-
PvML1 suppresses bacterial infection by recognizing LPS and regulating AMP expression in shrimp.Front Immunol. 2022 Dec 28;13:1088862. doi: 10.3389/fimmu.2022.1088862. eCollection 2022. Front Immunol. 2022. PMID: 36643915 Free PMC article.
-
Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling.J Immunol. 2008 Jan 15;180(2):1139-47. doi: 10.4049/jimmunol.180.2.1139. J Immunol. 2008. PMID: 18178854 Free PMC article.
-
Zhankuic acid A isolated from Taiwanofungus camphoratus is a novel selective TLR4/MD-2 antagonist with anti-inflammatory properties.J Immunol. 2014 Mar 15;192(6):2778-86. doi: 10.4049/jimmunol.1301931. Epub 2014 Feb 14. J Immunol. 2014. PMID: 24532584 Free PMC article.
-
Bacterial Lipoproteins Induce BAFF Production via TLR2/MyD88/JNK Signaling Pathways in Dendritic Cells.Front Immunol. 2020 Oct 2;11:564699. doi: 10.3389/fimmu.2020.564699. eCollection 2020. Front Immunol. 2020. PMID: 33123136 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous